FotoFinder® ATBM master
Showing 26 - 50 of >10,000
Post Traumatic Stress Disorder Trial (Intervention C Daridorexant, Intervention C Placebo)
Not yet recruiting
- Post Traumatic Stress Disorder
- Intervention C Daridorexant
- Intervention C Placebo
- (no location specified)
Jul 5, 2023
Post Traumatic Stress Disorder Trial (Intervention B Vilazodone Hydrochloride, Intervention B Placebo)
Not yet recruiting
- Post Traumatic Stress Disorder
- Intervention B Vilazodone Hydrochloride
- Intervention B Placebo
- (no location specified)
Jul 5, 2023
Post Traumatic Stress Disorder Trial (Intervention A Fluoxetine HCl, Intervention A Placebo)
Not yet recruiting
- Post Traumatic Stress Disorder
- Intervention A Fluoxetine HCl
- Intervention A Placebo
- (no location specified)
Jul 5, 2023
2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease Trial in Miami (Famotidine, Celecoxib,
Active, not recruiting
- 2019 Novel Coronavirus Disease
- +11 more
- Famotidine
- +2 more
-
Miami, FloridaUS02-04: Integrated Health Solutions
Aug 15, 2022
Lumbar Disc Herniation, Degenerative Spinal Stenosis, Spine Traction Trial (Ceragem Master V6 Traction, Physical therapy with
Recruiting
- Lumbar Disc Herniation
- +2 more
- Ceragem Master V6 Traction
- Physical therapy with standard traction device
-
Jeonju, Korea, Republic ofPresbyterian Medical Center
Jan 5, 2023
Artificial Intelligent Accelerates Learning Curve for Mastering
Recruiting
- Thyroid Nodule
- Artificial Intelligent
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Aug 8, 2023
Acute Myeloid Leukemia, MDS Trial (SPRX002, ARC-T)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- SPRX002
- ARC-T
- (no location specified)
Jul 12, 2022
Advanced Malignancies, NSCLC, Ovarian Cancer Trial in Worldwide (Avelumab, Lorlatanib, Talazoparib)
Recruiting
- Advanced Malignancies
- +4 more
- Avelumab
- +7 more
-
Fayetteville, Arkansas
- +61 more
Jan 10, 2023
Chronic Disease Trial in Birmingham, Jackson (Harvest for Health)
Completed
- Chronic Disease
- Harvest for Health
-
Birmingham, Alabama
- +1 more
Dec 13, 2022
Type 2 Diabetes, Obesity, Overweight Trial in Worldwide (Retatrutide, Placebo)
Not yet recruiting
- Type 2 Diabetes
- +3 more
- Retatrutide
- Placebo
-
Los Angeles, California
- +91 more
Jul 10, 2023
Parenting Trial in Altoona, McKeesport (Caregiver Skills Training (CST))
Recruiting
- Parenting
- Caregiver Skills Training (CST)
-
Altoona, Pennsylvania
- +1 more
Sep 15, 2023
Two Swept Source Optical Coherence Tomography Biometers
Completed
- Cataract
- Argos
- IOLMaster 700
-
Frankfort, IllinoisMultack Eye Care
Feb 17, 2023
Artificial Intelligence Trial in Wuhan (Artificial intelligence assisted system)
Not yet recruiting
- Artificial Intelligence
- Artificial intelligence assisted system
-
Wuhan, Hubei, ChinaRenmin Hospital of Wuhan University
Jun 19, 2022
Ventricular Fibrillation, Ventricular Tachycardia, Heart Failure Trial in Germany (SD01 ICD lead)
Active, not recruiting
- Ventricular Fibrillation
- +2 more
- SD01 ICD lead
-
Berlin, Germany
- +9 more
Jul 7, 2022
Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Acapatamab, Enzalutamide, Abiraterone)
Active, not recruiting
- Metastatic Castration-resistant Prostate Cancer
- Acapatamab
- +3 more
-
Birmingham, Alabama
- +13 more
Jun 20, 2022
Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,
Not yet recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- +4 more
- Decitabine
- +3 more
-
Utrecht, NetherlandsPrincess Máxima Center for Pediatric Oncology
Feb 22, 2023
Alcohol-Related Disorders Trial in Los Angeles (Dihydromyricetin)
Not yet recruiting
- Alcohol-Related Disorders
-
Los Angeles, CaliforniaUniversity of Southern California
Nov 11, 2022
Head and Neck Squamous Cell Carcinoma Trial in United States (TAK-676, Carboplatin, 5-FU)
Completed
- Head and Neck Squamous Cell Carcinoma
- TAK-676
- +8 more
-
Shreveport, Louisiana
- +3 more
Oct 3, 2023
Percutaneous Nephrolithotomy Trial in Hengyang (one-handed technique)
Recruiting
- Percutaneous Nephrolithotomy
- one-handed technique
-
Hengyang, Hunan, ChinaThe First Affiliated Hospital of University of South China
Jan 30, 2023